New radiation approach shows promise for mesothelioma patients
NCT ID NCT03269227
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new way to give radiation therapy to people with malignant pleural mesothelioma, a rare and serious lung cancer. The treatment uses a special machine called Tomotherapy to deliver high doses of radiation over just 5 days. The goal is to see if this short, intense treatment is safe and helps control the disease after surgery. The study includes 30 adults aged 18 to 85 with good overall health.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT PLEURAL MESOTHELIOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
SC Radiotherapy
Meldola, 47014, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Chest-Injected drug drain Cancer's fluid trap?
- Can a pill that blocks multiple cancer proteins shrink Hard-to-Treat tumors?
- Triple-Drug cocktail targets Hard-to-Treat mesothelioma
- New antibody-chemo combo shows promise for mesothelioma
- Triple threat: new combo tackles rare lung cancer
- Immunotherapy before surgery shows promise for mesothelioma patients